Microbot Debt To Equity from 2010 to 2024
| MBOT Stock | USD 1.16 0.02 1.75% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.05132193 | Current Value 0.0539 | Quarterly Volatility 8.08899689 |
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.7 K, Total Revenue of 0.0 or Other Operating Expenses of 14.3 M, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 0.0 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
Microbot | Debt To Equity |
Latest Microbot Medical's Debt To Equity Growth Pattern
Below is the plot of the Debt To Equity of Microbot Medical over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Microbot Medical's Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.07 % | 10 Years Trend |
|
Debt To Equity |
| Timeline |
Microbot Debt To Equity Regression Statistics
| Arithmetic Mean | (1.80) | |
| Coefficient Of Variation | (449.57) | |
| Mean Deviation | 3.89 | |
| Median | 0.05 | |
| Standard Deviation | 8.09 | |
| Sample Variance | 65.43 | |
| Range | 33.4985 | |
| R-Value | 0.10 | |
| Mean Square Error | 69.75 | |
| R-Squared | 0.01 | |
| Significance | 0.72 | |
| Slope | 0.18 | |
| Total Sum of Squares | 916.05 |
Microbot Debt To Equity History
About Microbot Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Microbot Medical income statement, its balance sheet, and the statement of cash flows. Microbot Medical investors use historical funamental indicators, such as Microbot Medical's Debt To Equity, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may use each financial statement separately, they are all related. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Microbot Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Microbot Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Microbot Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | 0.05 | 0.05 |
Pair Trading with Microbot Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbot Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Microbot Stock
| 0.67 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
Moving against Microbot Stock
| 0.53 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.46 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Microbot Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbot Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbot Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbot Medical to buy it.
The correlation of Microbot Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbot Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbot Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbot Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.